Autopsy report · NCT00535821

Minimally-Invasive Cardiovascular Hemodynamic Optimization (MiCHO) Versus Early Goal-Directed Therapy (EGDT) in the Management of Septic Shock

“slow enrollement unavailable technology”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months after it had already started.
• Ran for about 3 years 3 months before it stopped.
• 5 participants enrolled.
• Results were posted on the registry 3 years 9 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

Loma Linda University

Sponsor type

University, hospital or other

Conditions

Severe Sepsis; Septic Shock

Interventions

Esophageal Doppler monitoring - CardioQ, Deltex Inc; Central line with CVP and continuous ScvO2 monitoring

Participants

5

Sites

4

Countries

United States

Trials that died the same way

• Painless Subconjunctival Antibiotic and Antifungal Injection in Corneal Ulcer Patients
  “Very slow in enrolling participants” (76% match in meaning)
• Rapid Pleurodesis Through an Indwelling Pleural Catheter
  “Slow enrollment” (74% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.